Literature DB >> 20870200

Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study.

Simerjot K Jassal1, Michel Chonchol, Denise von Mühlen, Gerard Smits, Elizabeth Barrett-Connor.   

Abstract

BACKGROUND: recent systematic reviews have cast doubt on the association between vitamin D and cardiovascular disease. No prior studies have investigated the association between 25-hydroxyvitamin D (25[OH]D), 1,25-dihydroxyvitamin D (1,25[OH](2)D), or intact parathyroid hormone and cardiovascular mortality in a temperate climate.
METHODS: a total of 1073 community-dwelling older adults were evaluated in 1997-1999; serum levels of 25(OH)D (mean 42 ng/mL), 1,25(OH)(2)D (median 29 pg/mL), and intact parathyroid hormone (median 46 pg/mL) were measured; mean estimated glomerular filtration rate was 74 mL/min/1.73 m(2). Participants were followed up to 10.4 (mean 6.4) years with 111 cardiovascular deaths.
RESULTS: in unadjusted Cox proportional hazards models, higher levels of 1,25(OH)(2)D were protective against cardiovascular mortality, whereas higher levels of intact parathyroid hormone predicted increased risk of cardiovascular death. After adjusting for age alone or multiple covariates, there was no significant association between 25(OH)D, 1,25(OH)(2)D, or intact parathyroid hormone and cardiovascular mortality; results did not differ by an estimated glomerular filtration rate ≥ 60 mL/min/1.73 m(2) or<60 mL/min/1.73 m(2).
CONCLUSION: in this prospective study of Caucasian, middle-income, community-dwelling older adults living in sunny southern California, serum levels of 25(OH)D, 1,25(OH)(2)D, and intact parathyroid hormone were not independently associated with cardiovascular mortality. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870200      PMCID: PMC3010282          DOI: 10.1016/j.amjmed.2010.07.013

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  33 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D.

Authors:  T C Chen; A K Turner; M F Holick
Journal:  J Nutr Biochem       Date:  1990-06       Impact factor: 6.048

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

4.  The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group.

Authors: 
Journal:  Prev Med       Date:  1976-06       Impact factor: 4.018

5.  Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study.

Authors:  Denise G von Mühlen; Gail A Greendale; Cedric F Garland; Lori Wan; Elizabeth Barrett-Connor
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

6.  Differences between respondents and non-respondents in a population-based cardiovascular disease study.

Authors:  M H Criqui; E Barrett-Connor; M Austin
Journal:  Am J Epidemiol       Date:  1978-11       Impact factor: 4.897

7.  Stability of parathyroid hormone ex vivo in haemodialysis patients.

Authors:  T K Teal; M Reed; P E Stevens; E J Lamb
Journal:  Ann Clin Biochem       Date:  2003-03       Impact factor: 2.057

8.  Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.

Authors:  Jared P Reis; Denise von Mühlen; Donna Kritz-Silverstein; Deborah L Wingard; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-03-10       Impact factor: 19.112

Review 9.  Systematic review: Vitamin D and cardiometabolic outcomes.

Authors:  Anastassios G Pittas; Mei Chung; Thomas Trikalinos; Joanna Mitri; Michael Brendel; Kamal Patel; Alice H Lichtenstein; Joseph Lau; Ethan M Balk
Journal:  Ann Intern Med       Date:  2010-03-02       Impact factor: 25.391

10.  Vitamin D status and the risk of cardiovascular disease death.

Authors:  Annamari Kilkkinen; Paul Knekt; Antti Aro; Harri Rissanen; Jukka Marniemi; Markku Heliövaara; Olli Impivaara; Antti Reunanen
Journal:  Am J Epidemiol       Date:  2009-09-17       Impact factor: 4.897

View more
  12 in total

1.  Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.

Authors:  Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; Stacey E Jolly; Anil Jain; Martin J Schreiber; James F Simon; Titte R Srinivas; Joseph V Nally
Journal:  Am J Kidney Dis       Date:  2011-08-04       Impact factor: 8.860

2.  Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease.

Authors:  Jessica Kendrick; Alfred K Cheung; James S Kaufman; Tom Greene; William L Roberts; Gerard Smits; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2012-05-22       Impact factor: 8.860

Review 3.  Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies.

Authors:  Lu Wang; Yiqing Song; Joann E Manson; Stefan Pilz; Winfried März; Karl Michaëlsson; Annamari Lundqvist; Simerjot K Jassal; Elizabeth Barrett-Connor; Cuilin Zhang; Charles B Eaton; Heidi T May; Jeffrey L Anderson; Howard D Sesso
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-11-13

4.  Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease.

Authors:  Anton Lishmanov; Smrita Dorairajan; Youngju Pak; Kunal Chaudhary; Anand Chockalingam
Journal:  Int Urol Nephrol       Date:  2011-02-15       Impact factor: 2.370

5.  Kidney function and progression of coronary artery calcium in community-dwelling older adults (from the Rancho Bernardo Study).

Authors:  Simerjot Kaur Jassal; Michel Chonchol; Gail A Laughlin; Kevin M Cummins; Gerard Smits; Caroline K Kramer; Joachim H Ix; Elizabeth Barrett-Connor
Journal:  Am J Cardiol       Date:  2012-08-08       Impact factor: 2.778

6.  Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Authors:  J-J Body; P Bergmann; S Boonen; J-P Devogelaer; E Gielen; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-02-04       Impact factor: 4.507

7.  Total 25-hydroxyvitamin D concentration as a predictor for all-cause death and cardiovascular event risk among ethnic Chinese adults: a cohort study in a Taiwan community.

Authors:  Kuo-Liong Chien; Hsiu-Ching Hsu; Pei-Chun Chen; Hung-Ju Lin; Ta-Chen Su; Ming-Fong Chen; Yuan-Teh Lee
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

8.  Low serum vitamin D levels increase the mortality of cardiovascular disease in older adults: A dose-response meta-analysis of prospective studies.

Authors:  Jun Yang; Juan Ou-Yang; Ji Huang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

9.  Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients.

Authors:  Cristina Căpuşa; Gabriel Stefan; Simona Stancu; Andrea Ilyes; Nicoleta Dorobanţu; Gabriel Mircescu
Journal:  Arch Med Sci       Date:  2016-08-24       Impact factor: 3.318

10.  Vitamin D Status and Mortality: A Systematic Review of Observational Studies.

Authors:  Alicia K Heath; Iris Y Kim; Allison M Hodge; Dallas R English; David C Muller
Journal:  Int J Environ Res Public Health       Date:  2019-01-29       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.